Paper Details
- Home
- Paper Details
Disease and Treatment-Related Burden in Patients With Acromegaly Who Are Biochemically Controlled on Injectable Somatostatin Receptor Ligands.
Author: BiermaszNienke R, CrosbyRoss D, DrevalAlexander, FleseriuMaria, Gilgun-SherkiYossi, GordonMurray B, HavivAsi, LudlamWilliam H, MathiasSusan D, MolitchMark
Original Abstract of the Article :
Medical treatment for acromegaly commonly involves receiving intramuscular or deep subcutaneous injections of somatostatin receptor ligands (SRLs) in most patients. In addition to side effects of treatment, acromegaly patients often still experience disease symptoms even when therapy is successful i...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006928/
データ提供:米国国立医学図書館(NLM)
Disease and Treatment-Related Burden in Patients with Acromegaly
This study explores the disease and treatment-related burden experienced by patients with acromegaly who are biochemically controlled on injectable somatostatin receptor ligands (SRLs). The research utilizes a questionnaire-based approach to assess the impact of acromegaly symptoms and treatment-related side effects on patients' quality of life. The study aimed to understand the persistent challenges faced by patients even after achieving biochemical control.
Living with Acromegaly: A Persistent Challenge
The study's findings highlight the significant disease burden that persists for patients with acromegaly, even after achieving biochemical control with SRLs. The study found that a majority of patients continue to experience acromegaly symptoms that interfere with their daily lives. Furthermore, gastrointestinal side effects and injection site reactions were common, further impacting patients' quality of life.
Optimizing Treatment Strategies for Acromegaly: A Multifaceted Approach
The study underscores the need for comprehensive and individualized treatment approaches for acromegaly. The research highlights the importance of addressing not only biochemical control but also the ongoing symptoms and side effects that may impact patient well-being. Further research is needed to explore strategies for mitigating these challenges and improving the overall experience for patients with acromegaly.
Dr.Camel's Conclusion
Living with acromegaly, like navigating a desert with its unpredictable shifts in temperature and terrain, presents a unique set of challenges. This study sheds light on the persistent burden of the disease and its treatment, even after achieving biochemical control. The findings encourage a more nuanced approach to managing acromegaly, focusing on both biochemical control and improving the overall quality of life for patients.
Date :
- Date Completed 2021-12-16
- Date Revised 2021-12-16
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.